What is the most recent FDA action against SUN PHARMACEUTICAL INDUSTRIES INC?

The most recent FDA event Argus HQ has on file for SUN PHARMACEUTICAL INDUSTRIES INC is dated 2026-07-01, with a severity rating of "critical" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for SUN PHARMACEUTICAL INDUSTRIES INC automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to SUN PHARMACEUTICAL INDUSTRIES INC is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for SUN PHARMACEUTICAL INDUSTRIES INC?

8 total: 0 warning letters, 8 recalls, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for SUN PHARMACEUTICAL INDUSTRIES INC?

July 1, 2026. Argus HQ ingests new FDA enforcement records daily.

Regulatory Record: SUN PHARMACEUTICAL INDUSTRIES INC

FDA action counts

Total FDA actions	8
Warning letters	0
Recalls	8
Approval records	0
Form 483 inspection citations	0
Most recent action	July 1, 2026

Key takeaway: Argus HQ has recorded 8 FDA events for SUN PHARMACEUTICAL INDUSTRIES INC: 0 warning letters, 8 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-04-22 to 2026-07-01. The most severe rating Argus HQ has assigned across this history is "critical". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Enforcement history

On 2026-04-22, Argus HQ recorded a FDA recall for SUN PHARMACEUTICAL INDUSTRIES INC, rated "high" severity in Argus HQ's classification: SUN PHARMACEUTICAL INDUSTRIES INC — Class II recall: Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceuticals… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-22, Argus HQ recorded a FDA recall for SUN PHARMACEUTICAL INDUSTRIES INC, rated "high" severity in Argus HQ's classification: SUN PHARMACEUTICAL INDUSTRIES INC — Class II recall: Fluocinonide, USP, 0.05% Cream, 30g tube, Rx only, Mfd by: Taro Pharmaceuticals… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-22, Argus HQ recorded a FDA recall for SUN PHARMACEUTICAL INDUSTRIES INC, rated "high" severity in Argus HQ's classification: SUN PHARMACEUTICAL INDUSTRIES INC — Class II recall: Fluocinonide, USP, 0.05% Cream, 60g tube, Rx only, Mfd by: Taro Pharmaceuticals… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for SUN PHARMACEUTICAL INDUSTRIES INC, rated "high" severity in Argus HQ's classification: SUN PHARMACEUTICAL INDUSTRIES INC — Class II recall: Xyvona (levorphanol tartrate tablets), 3mg, 100 Tablets, Rx only, Forte BioPharm… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for SUN PHARMACEUTICAL INDUSTRIES INC, rated "high" severity in Argus HQ's classification: SUN PHARMACEUTICAL INDUSTRIES INC — Class II recall: Xyvona (levorphanol tartrate tablets), 2mg, 100 Tablets, Rx only, Forte BioPharm… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-17, Argus HQ recorded a FDA recall for SUN PHARMACEUTICAL INDUSTRIES INC, rated "high" severity in Argus HQ's classification: SUN PHARMACEUTICAL INDUSTRIES INC — Class II recall: Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-17, Argus HQ recorded a FDA recall for SUN PHARMACEUTICAL INDUSTRIES INC, rated "critical" severity in Argus HQ's classification: SUN PHARMACEUTICAL INDUSTRIES INC — Class I recall: DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-d… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-07-01, Argus HQ recorded a FDA recall for SUN PHARMACEUTICAL INDUSTRIES INC, rated "high" severity in Argus HQ's classification: SUN PHARMACEUTICAL INDUSTRIES INC — Class II recall: Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical I… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. In total, SUN PHARMACEUTICAL INDUSTRIES INC has 8 FDA events on file with Argus HQ across the sources Argus HQ currently tracks (FDA Warning Letters, recalls, drug/biologic approvals, and Form 483 inspection observations).

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. SUN PHARMACEUTICAL INDUSTRIES INC has 8 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

What is the most recent FDA action against SUN PHARMACEUTICAL INDUSTRIES INC?: The most recent FDA event Argus HQ has on file for SUN PHARMACEUTICAL INDUSTRIES INC is dated 2026-07-01, with a severity rating of "critical" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Does Argus HQ track new FDA actions for SUN PHARMACEUTICAL INDUSTRIES INC automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to SUN PHARMACEUTICAL INDUSTRIES INC is observed, this page's event count and history update automatically.
How many FDA actions does Argus HQ track for SUN PHARMACEUTICAL INDUSTRIES INC?: 8 total: 0 warning letters, 8 recalls, 0 approval records, and 0 Form 483 inspection citations.
What is the most recent FDA action on file for SUN PHARMACEUTICAL INDUSTRIES INC?: July 1, 2026. Argus HQ ingests new FDA enforcement records daily.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Regulatory Record: SUN PHARMACEUTICAL INDUSTRIES INC. Digital Empire LLC. Retrieved from https://argushq.ai/company/sun-pharmaceutical-industries-inc

MLA

"Regulatory Record: SUN PHARMACEUTICAL INDUSTRIES INC." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/sun-pharmaceutical-industries-inc.

Chicago

Argus HQ Research. "Regulatory Record: SUN PHARMACEUTICAL INDUSTRIES INC." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/sun-pharmaceutical-industries-inc.

BibTeX

@misc{argushq_argushq_ai_company_sun_pharmaceutical_industries_inc_2026,
  title = {Regulatory Record: SUN PHARMACEUTICAL INDUSTRIES INC},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/company/sun-pharmaceutical-industries-inc},
  note = {Accessed: July 13, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗